Pharmaceuticals (298) | Stock Agreements (298)
Browse by Company
-
ACELRX PHARMACEUTICALS INC (2)
-
Acer Therapeutics Inc. (1)
-
Acreage Holdings, Inc. (6)
-
ACURA PHARMACEUTICALS, INC (1)
-
Adamis Pharmaceuticals Corp (4)
-
ADIAL PHARMACEUTICALS, INC. (1)
-
AERIE PHARMACEUTICALS INC (1)
-
AGILE THERAPEUTICS INC (5)
-
Akers Biosciences, Inc. (2)
-
Akorn (1)
-
Amag Pharmaceuticals (2)
-
Ampio Pharmaceuticals, Inc. (3)
-
ANI Pharma Inc (3)
-
Applied BioSciences Corp. (2)
-
APRICUS BIOSCIENCES, INC. (1)
-
Aquestive Therapeutics, Inc. (2)
-
ARVINAS, INC. (1)
-
AXIM BIOTECHNOLOGIES, INC. (2)
-
Baudax Bio, Inc. (3)
-
BioPharmX Corp (5)
-
Boston Therapeutics, Inc. (1)
-
Bristol-Myers Squibb (1)
-
Canbiola, Inc. (5)
-
CANNAPHARMARX, INC. (1)
-
Canopy Growth Corp (4)
-
Cara Therapeutics, Inc. (2)
-
CARDAX, INC. (1)
-
CASSAVA SCIENCES INC (1)
-
Catalent Inc (5)
-
Cerecor Inc. (2)
-
CHIASMA, INC (1)
-
Citius Pharmaceuticals, Inc. (1)
-
Clearside Biomedical, Inc. (1)
-
Cocrystal Pharma, Inc. (1)
-
Corcept Therapeutics Incorporated (2)
-
CorMedix Inc. (1)
-
Cronos Group Inc. (5)
-
CUMBERLAND PHARMACEUTICALS INC (1)
-
Cure Pharmaceutical Holding Corp. (2)
-
CymaBay Therapeutics, Inc. (3)
-
DURECT CORP (3)
-
Elanco Animal Health Inc (9)
-
Evofem Biosciences, Inc. (2)
-
Exactus, Inc. (5)
-
EyePoint Pharmaceuticals, Inc. (1)
-
Fulcrum Therapeutics, Inc. (2)
-
Horizon Pharma plc (1)
-
Hoth Therapeutics, Inc. (1)
-
IMARA Inc. (3)
-
IntelGenx Technologies Corp. (1)
-
Intersect ENT, Inc. (1)
-
Intra-Cellular Therapies, Inc. (2)
-
Jaguar Health, Inc. (7)
-
Jazz Pharmaceuticals plc (6)
-
Johnson & Johnson (1)
-
Kala Pharmaceuticals, Inc. (2)
-
Kaleido Biosciences, Inc. (2)
-
Kannalife Inc (1)
-
KEMPHARM, INC (1)
-
Lannett Company, Inc. (1)
-
Lilly (Eli) & Co. (12)
-
Liquidia Corp (3)
-
Liquidia Technologies Inc (2)
-
Lyra Therapeutics, Inc. (4)
-
Medicine Man Technologies, Inc. (3)
-
Menlo Therapeutics Inc. (1)
-
Merck (1)
-
MICROCHANNEL TECHNOLOGIES CORP (6)
-
Milestone Pharmaceuticals Inc. (3)
-
MJ Holdings, Inc. (4)
-
MYnd Analytics, Inc. (3)
-
MyoKardia Inc (2)
-
NEKTAR THERAPEUTICS (1)
-
Neos Therapeutics, Inc. (1)
-
NGM BIOPHARMACEUTICALS INC (4)
-
NovaBay Pharmaceuticals, Inc. (2)
-
Novan, Inc. (4)
-
OCULAR THERAPEUTIX, INC (1)
-
OMEROS CORP (2)
-
Onconova Therapeutics, Inc. (2)
-
OptiNose, Inc. (1)
-
ORAMED PHARMACEUTICALS INC. (1)
-
Pacira Pharmaceuticals, Inc. (1)
-
Panacea Acquisition Corp (6)
-
Perrigo (1)
-
Pfizer (2)
-
Phathom Pharmaceuticals, Inc. (3)
-
PLIANT THERAPEUTICS, INC. (2)
-
PLx Pharma Inc. (1)
-
Processa Pharmaceuticals, Inc. (1)
-
ProPhase Labs, Inc. (2)
-
PROTEO INC (3)
-
Provention Bio, Inc. (1)
-
QUANTA INC (2)
-
REATA PHARMACEUTICALS INC (9)
-
Recro Pharma, Inc. (6)
-
RespireRx Pharmaceuticals Inc. (9)
-
resTORbio, Inc. (3)
-
Revance Therapeutics, Inc. (1)
-
Satsuma Pharmaceuticals, Inc. (5)
-
Scopus BioPharma Inc. (1)
-
SCYNEXIS INC (7)
-
SenesTech, Inc. (1)
-
Strongbridge Biopharma plc (1)
-
Target Group Inc. (1)
-
Teligent, Inc. (3)
-
Tenzing Acquisition Corp. (1)
-
Terra Tech Corp. (7)
-
TETRAPHASE PHARMACEUTICALS INC (1)
-
TFF Pharmaceuticals, Inc. (2)
-
TITAN PHARMACEUTICALS INC (1)
-
Trevi Therapeutics, Inc. (2)
-
Tricida, Inc. (3)
-
Trulieve Cannabis Corp. (1)
-
Urovant Sciences Ltd. (1)
-
Verrica Pharmaceuticals Inc. (1)
-
VIVUS INC (1)
-
Wize Pharma, Inc. (1)
Recent Contracts
-
Restricted Stock Unit Grant Agreement (U.S. Employees) (For Settlement in Common Shares Only)
(Canopy Growth Corp, Filed With SEC on June 14, 2021)
-
Restricted Stock Unit Grant Agreement (For Non-U.S. Employees) (For Settlement in Common Shares Only)
(Canopy Growth Corp, Filed With SEC on June 14, 2021)
-
Stock Purchase Agreement between Terra Tech Corp. and Sterling Harlan and Matthew Guild, dated June 9, 2021
(Terra Tech Corp., Filed With SEC on June 10, 2021)
-
Description of Capital Stock of Canopy Growth Corporation
(Canopy Growth Corp, Filed With SEC on June 1, 2021)
-
Acura Pharmaceuticals Inc. 2021 Restricted Stock Unit Award Plan
(ACURA PHARMACEUTICALS, INC, Filed With SEC on May 27, 2021)
-
Elanco Animal Health Incorporated Amended and Restated 2018 Elanco Stock Plan (including related form agreements)
(Elanco Animal Health Inc, Filed With SEC on May 21, 2021)
-
Amendment to Stock Purchase Agreement dated as of April 27, 2021 by and among High Street Capital Partners, LLC, RWB Florida LLC and Red White & Bloom Brands Inc
(Acreage Holdings, Inc., Filed With SEC on May 10, 2021)
-
Form of Elanco Animal Health Incorporated Restricted Stock Unit Award Agreement for executives with respect to annual awards
(Elanco Animal Health Inc, Filed With SEC on May 7, 2021)
-
Notice of Grant of Restricted Stock Units for employees, dated as of December 2, 2020
(REATA PHARMACEUTICALS INC, Filed With SEC on May 6, 2021)
-
Form of Stock Option Award under Provention Bio, Inc. 2020 Inducement Plan (, Exhibit 10.1)
(Provention Bio, Inc., Filed With SEC on May 6, 2021)
